Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
103.45
-1.38 (-1.32%)
Feb 25, 2026, 2:01 PM EST - Market open
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $20 billion as of February 25, 2026. Its market cap has increased by 156.51% in one year.
Market Cap
20.00B
Enterprise Value
19.00B
1-Year Change
156.51%
Ranking
Category
Stock Price
$103.45
Market Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $20.00B, an increase of 1,116.13%. That is a compound annual growth rate of 51.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 20.27B | 31.61% |
| Dec 31, 2025 | 15.40B | 90.50% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioNTech SE | 27.82B |
| Royalty Pharma | 26.19B |
| Roivant Sciences | 20.23B |
| Incyte | 20.11B |
| Moderna | 19.95B |
| Genmab | 17.99B |
| Ascendis Pharma | 14.42B |
| Ionis Pharmaceuticals | 13.84B |